Can't find or afford Cequa? Here are the best alternatives for dry eye disease in 2026, including Restasis, Xiidra, Vevye, and Tyrvaya — with costs and key differences.
If you've been prescribed Cequa (Cyclosporine ophthalmic solution 0.09%) for dry eye disease but can't fill your prescription — whether because of cost, insurance denial, or availability — you're not out of options. Several other FDA-approved medications treat dry eye disease effectively, and your doctor can help you find one that works for your situation.
In this guide, we'll explain what Cequa does, how it works, and walk through the most common alternatives available in 2026.
Cequa is a prescription eye drop approved by the FDA in 2018 to increase tear production in adults with dry eye disease. It's made by Sun Pharmaceutical Industries and contains cyclosporine at a 0.09% concentration — delivered using a proprietary NCELL nanomicellar technology designed to improve how well the drug reaches the surface of your eye.
Cyclosporine is a calcineurin inhibitor. In simple terms, it blocks a protein that triggers inflammation on the surface of your eyes. When that inflammation is reduced, your tear glands can function better and produce more natural tears.
You use Cequa by placing one drop in each eye twice a day, using a fresh single-use vial each time. For a deeper dive into the science, see our article on how Cequa works.
Cequa is a good medication, but several factors push patients toward alternatives:
Here are the most common alternatives your eye doctor may consider. Each one works a bit differently, so the best choice depends on your specific situation, insurance coverage, and how your eyes respond.
What it is: Restasis was the first cyclosporine eye drop approved for dry eye, hitting the market in 2003. It contains a lower concentration of cyclosporine (0.05%) compared to Cequa's 0.09%.
How it works: Same mechanism as Cequa — it's a calcineurin inhibitor that reduces ocular inflammation to help your eyes produce more tears.
Key differences from Cequa:
Cost: Brand Restasis ~$400/month; generic cyclosporine 0.05% ~$90/month
Best for: Patients who need an affordable cyclosporine option or whose insurance requires trying generic cyclosporine first.
What it is: Xiidra is a prescription eye drop that takes a completely different approach to treating dry eye. Rather than using cyclosporine, it contains lifitegrast — an LFA-1 antagonist.
How it works: Xiidra blocks a specific protein (LFA-1) on the surface of immune cells that drives inflammation in dry eye. By preventing these immune cells from binding to the eye's surface, Xiidra reduces inflammation and can improve both signs and symptoms of dry eye.
Key differences from Cequa:
Cost: ~$1,000/month without insurance
Best for: Patients who haven't responded to cyclosporine products or want a non-cyclosporine option.
What it is: Vevye is the newest cyclosporine eye drop, approved by the FDA in 2023. It contains a slightly higher concentration of cyclosporine (0.1%) in a unique water-free, preservative-free formulation.
How it works: Same calcineurin-inhibiting mechanism as Cequa and Restasis, but the water-free vehicle may improve comfort and drug delivery.
Key differences from Cequa:
Cost: ~$1,070/month without insurance
Best for: Patients looking for a newer cyclosporine formulation, especially those who prefer a multi-dose bottle over single-use vials.
What it is: Tyrvaya is a completely different kind of dry eye treatment — it's a nasal spray, not an eye drop. Approved by the FDA in 2021, it takes a novel approach to stimulating tear production.
How it works: Tyrvaya activates the trigeminal nerve through the nasal passages, which signals the lacrimal glands to produce more tears. It targets the root cause of tear deficiency without putting anything directly in your eyes.
Key differences from Cequa:
Cost: ~$930/month without insurance
Best for: Patients who can't tolerate eye drops or haven't responded to anti-inflammatory approaches.
While not direct replacements for Cequa, over-the-counter artificial tears can help manage mild dry eye symptoms while you work on getting a prescription medication. Popular options include:
Artificial tears provide temporary relief by supplementing your natural tear film, but they don't address the underlying inflammation that causes dry eye disease. Your doctor will likely recommend them as a complement to — not a replacement for — prescription treatment.
Choosing the right alternative to Cequa depends on several factors:
Talk to your ophthalmologist or optometrist about which option makes the most sense for your eyes, your insurance, and your preferences.
Not being able to fill your Cequa prescription is frustrating, but dry eye disease has more treatment options in 2026 than ever before. Whether it's a more affordable generic cyclosporine, a different drug class like Xiidra, a newer formulation like Vevye, or an entirely different approach like Tyrvaya, there's likely an alternative that can help.
If availability is the issue rather than cost, check out our guide on how to find Cequa in stock near you — you may be able to locate it with the right tools. And for savings options on brand-name Cequa, visit our guide to saving money on Cequa.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
